Principal Investigator in more than 70 clinical trials several of which were combined with translational research. More important, however, was the successful claiming of several competitive Research Grants as a lead researcher in the USA and Greece. Indicative:
- American Cancer Society (ACS) Career Development Award "Neutral endopeptidase (CD10) as a therapeutic target in the treatment of solid tumors and in particular prostate cancer" (1997-2000, $ 245,000-Cornell-MSKCC & UT-MDACC)
- Targeted detection of prostate cancer using nano-particles and nano-magnetic tomography (2011-2014, € 623,297 - University of Thessaly)
- Innovation Research Plans (NSRF 2014-2020) for the project with code KMP6-0079506 and title: "Integrated Oncology Patient Management System" (SADOA, € 375,000 - AUTh)